NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

Franklin Genomic Advancements ETF

This ETF provides exposure to Other Global Equities

HELX performance and flow charts

Last update 6/12/2026 at 1:30 PM
Live
Closed
Last price
$35.45
-$0.25 (-0.71%) 6/12/2026

Performance

-4.0-2.00.02.04.06.0%May 12May 19May 27Jun 3Jun 10

Flows

0
1 day price range
$35.45
$35.45
52 week price range
$27.00
$38.07
1W perf
+1.79%
YTD perf
-2.29%
YTD flows
+$2M
AuM
$23M
E/R
0.5%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of June 12, 2026
1M3MYTD1Y3Y5Y
Perf.+4.54%+10.40%-2.29%+28.69%+15.30%-24.55%
Flows--+$2M+$8M+$9M+$14M
Data as of June 12, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderFranklin Templeton
N° of holdings60
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateFebruary 25, 2020
ESGNo
TrackinsightTrackinsight

More data and info about HELX on Trackinsight

Exposure

Data as of April 30, 2026

Diversification

58.48%

Total weight of top 15 holdings out of 60

Top 15 Holdings

NATERA
6.86%
GUARDANT HEALTH INC
6.56%
KRYSTAL BIOTECH INC
5.67%
UTD THERAPEUT
4.48%
LIGAND PHARMACEUTICALS
4.31%
BRIDGEBIO PHARMA
4.28%
INSMED
3.8%
ASTRAZENECA
3.26%
ADAPTIVE BIOTECHNOLOGIES
3.23%
SAMSUNG BIOLOGICS CO LTD
3.14%
VERTEX PHARMACEUTICALS
2.87%
REGENERON PHARMACEUTICALS
2.6%
CORTEVA INC
2.58%
ALNYLAM PHARMACEUTICALS
2.44%
LILLY
2.39%

Sectors

Health Care
89.42%
Other
10.58%

Countries

USA
87.65%
Other
12.35%
Advertisement

Trading data

Last sale
6/12/2026 at 1:30 PM
$35.45
Previous close
$35.71
Consolidated volume
06/12/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+26.36%+21.07%+20.62%+23.64%
Max drawdown
-6.54%-17.89%-29.16%-58.50%
Max drawdown duration
38d194d458d1739d
Time to recover
10dN/A193dN/A
Advertisement
Frequently asked questions about HELX

What type of ETF is HELX?

HELX is a Active ETF that provides exposure to Equity assets. It is managed by Franklin Templeton.

What does HELX invest in?

This ETF provides exposure to Other Global Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of HELX?

The total expense ratio (TER) of HELX is 0.5%, representing the annual fee charged by the fund manager.

When was HELX launched?

HELX was launched on February 25, 2020, marking its entry into the ETF market.

Who is the issuer of HELX?

HELX is issued by Franklin Templeton.

What is the AUM of HELX?

As of June 12, 2026, HELX manages $23.05 M, reflecting the total assets held in the fund.

How has HELX performed recently?

As of June 12, 2026, HELX delivered a return of 4.54% over the past month (1M performance), 10.4% over the past three months (3M), and -2.29% year-to-date (YTD).

How many holdings are in HELX

As of April 30, 2026, HELX holds 60 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is HELX?

As of April 30, 2026, HELX holds 60 securities, with 58.48% of its assets concentrated in its top 15 holdings.

What are the top holdings of HELX?

As of April 30, 2026, HELX holds a portfolio of 60 underlyings, with its largest positions including NATERA, GUARDANT HEALTH INC and KRYSTAL BIOTECH INC. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does HELX invest in?

As of April 30, 2026, HELX has its largest geographic exposures in USA.

What sectors or themes does HELX focus on?

As of April 30, 2026, HELX is primarily exposed to Health Care.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

The ETF Show - New Autism-Impact ETF Launched

Asset TV

The ETF Show - New Autism-Impact ETF Launched

Defiance ETFs has launched the first ETF, $ASD, focused on the autism ecosystem, investing in companies that provide services, products, and research related to autism and neurodivergence.

Asset TV
By Asset TV · June 4, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs June 1, 2026

The ETF Industry saw 22 New Launches, 1 Ticker Change and 1 closure last week.

Tidal
By Tidal · June 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs May 20, 2026

The ETF Industry saw 44 New Launches, 3 Mutual Fund Conversions and 9 closures last week.

Tidal
By Tidal · May 19, 2026
The ETF Show - Politics Becomes Investable Trade through ETFs

Asset TV

The ETF Show - Politics Becomes Investable Trade through ETFs

Dan Weiskopf, Senior Portfolio Manager at Tidal Financial Group spoke with the ETF Show about Subversive ETFs that help investors trade like politicians.

Asset TV
By Asset TV · May 18, 2026

Browse all educational columns

Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up